BASF Narrows Its Gap to a Record High as Buybacks and Divestitures Reshape the Balance Sheet

BASF shares rally 21% YTD, near 52-week high, fueled by buybacks, strong Q2 beat, and coatings sale proceeds.

The chemicals giant's share price is within touching distance of its 52-week peak, a rally built on a foundation of portfolio pruning, aggressive capital returns, and quarterly numbers that blew past consensus estimates.

Shares in the Ludwigshafen-based group were changing hands at roughly €53.60 in recent sessions, leaving the stock just over 2 percent shy of the €55.05 high it set in April. The equity has climbed 21 percent since the start of the year, with the last 30 days alone accounting for a 6.2 percent advance. That momentum leaves the shares trading about 10 percent above their 200-day moving average, a technical marker of the sustained uptrend.

Buyback Cadence Accelerates

The shareholder remuneration machine has been running at full tilt. A fresh repurchase programme of up to €1.0 billion kicked off in August and is slated to run through April 2027, forming part of the €4 billion buyback framework unveiled back in September 2024 that extends to the end of 2028.

Execution has been swift. In the week of 17–21 August alone, BASF bought back 557,966 of its own shares, followed by a further 591,251 in the subsequent week. These purchases build on an earlier tranche worth roughly €1.5 billion completed between November 2025 and June 2026. More than 31.6 million shares — equivalent to nearly 3.5 percent of share capital — are earmarked for cancellation, a move that permanently shrinks the share count and lends structural support to earnings per share.

The buybacks are not happening in a vacuum. They are underpinned by an operating performance that has consistently beaten expectations. Preliminary second-quarter figures released in mid-July showed EBITDA before special items of €2.4 billion, comfortably ahead of the €2.1 billion analysts had pencilled in and up sharply from the €1.6 billion posted a year earlier. Revenue climbed 16 percent to €17.2 billion, driven by an 11.5 percent increase in prices and 7.3 percent volume growth.

That strength prompted management to lift its full-year guidance in late July. The group now expects EBITDA before special items of between €6.9 billion and €7.7 billion, a meaningful upgrade from the previous range of €6.2 billion to €7.0 billion. The free cash flow forecast remains unchanged at €1.5 billion to €2.3 billion.

The Coatings Windfall

The improved profitability coincides with a period of intense structural change. Just over a month ago, BASF completed the sale of its coatings business to Carlyle in a deal valuing the unit at €7.7 billion, generating a pre-tax cash inflow of €5.8 billion. The group retains a 40 percent equity stake in the divested business, now operating under the name Surventis.

The proceeds have been put to work. The share price has gained 14.8 percent since the transaction closed, and the early repayment of bonds and loans with a nominal volume of €1.6 billion — completed around a month ago — has contributed a further 6.5 percent rise. The balance sheet is visibly leaner as a result.

Portfolio Reshuffle Continues

The divestment programme shows no signs of slowing. In May, BASF signed an agreement to sell its silicates business and associated assets at the Düsseldorf/Holthausen site to PQ Corporation, with completion expected in the second half of 2026. The agricultural solutions division, meanwhile, closed its acquisition of AgBiTech from Paine Schwartz Partners at the end of March, strengthening its biological crop protection offering.

Attention is increasingly turning to a potential stock market listing for the agricultural division. Livio Tedeschi, who joined the executive board on 1 May alongside Mary Kurian — replacing Michael Heinz, who retired — reportedly said in August that the group would focus fully on a possible IPO next year, with the groundwork expected to be laid by mid-2027. Frankfurt is the preferred venue, and a listing as a Societas Europaea would mark a milestone in the group's "Winning Ways" strategy.

Expansion in Asia

Capital is also flowing into new capacity. In March, BASF officially inaugurated its new Verbund site in Zhanjiang, China — an investment of around €8.7 billion delivered on time and within budget. The site, spanning roughly four square kilometres and employing more than 2,000 people across over 70 products, is the group's seventh integrated production hub worldwide and ranks third in size after Ludwigshafen and Antwerp.

August brought the opening of a new performance lab for diapers and superabsorbents in Mumbai, consolidating technical services for global customers in the hygiene segment. The Asian expansion underscores a strategic tilt toward growth markets outside Europe.

Boardroom Confidence

Signals from within the company have been encouraging. Kurt Bock, a member of the supervisory board, purchased 2,330 BASF shares in early May at €53.63 apiece in a director's dealing — a vote of confidence that coincided with the improving earnings trajectory.

The supervisory board had earlier proposed Mark Garrett as a shareholder representative in February, and he was confirmed at the annual general meeting on 30 April.

Investors will get their next formal update on 28 October, when BASF publishes its third-quarter results.